Media: news releases

feature photo

World premiere of climate-disaster play at UVic

September 9, 2024 - Media release

People across Canada came together to help one another during recent climate disasters, and now Neworld Theatre is bringing those true-life stories to the stage. Eyes of the Beast: Climate Disaster Survivor Stories is the first full-length documentary theatre production based upon on-the-ground climate disaster reporting and will have its world premiere at the UVic's Phoenix Theatre from Sept. 16-21.

Read more: World premiere of climate-disaster play at UVic
feature photo

History lesson: Identifying a climate ‘tipping point’ for ocean deoxygenation

September 4, 2024 - Media release

Massive volcanic carbon dioxide (CO2) emissions contributing to an extreme global ocean deoxygenation event over 120 million years ago has modern day implications for understanding a climate warming “tipping point,” according to new research published in Nature this week, led by a scientist at Ocean Networks Canada, a UVic initiative.

Read more: History lesson: Identifying a climate ‘tipping point’ for ocean deoxygenation
feature photo

ONC welcomes new Tang.ɢwan — ḥačxʷiqak — Tsig̱is Marine Protected Area

July 11, 2024 - Media release

Ocean Networks Canada, a University of Victoria initiative, welcomes today’s announcement of the new marine protected area (MPA) Tang.ɢwan — ḥačxʷiqak — Tsig̱is (ThT) by the Haida Nation, Nuu-chah-nulth Tribal Council, Pacheedaht First Nation, Quatsino First Nation, and the Government of Canada.

Read more: ONC welcomes new Tang.ɢwan — ḥačxʷiqak — Tsig̱is Marine Protected Area
feature photo

Creating a vaccine for an ancient, all-too-current disease

June 10, 2024 - Media release

International researchers led by University of Victoria microbiologist Caroline Cameron are developing a vaccine for syphilis, an ancient disease that is, once again, increasingly prevalent. The National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) in the US is supporting the project with US$7.8 million over five years to engineer a hybrid protein with a goal of preventing infectious and congenital syphilis.  

Read more: Creating a vaccine for an ancient, all-too-current disease